{"indexed":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T12:08:54Z","timestamp":1525694934672},"reference-count":32,"publisher":"Springer Nature","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13075-015-0626-1","type":"article-journal","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T12:07:49Z","timestamp":1432123669000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":"Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis","prefix":"10.1186","volume":"17","author":[{"given":"Robert","family":"Landew\u00e9","sequence":"first","affiliation":[]},{"given":"Josef S","family":"Smolen","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Florentinus","sequence":"additional","affiliation":[]},{"given":"Su","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Beno\u00eet","family":"Gu\u00e9rette","sequence":"additional","affiliation":[]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,5,21]]},"reference":[{"key":"626_CR1","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/rheumatology\/35.11.1106","volume":"35","author":"E Fex","year":"1996","unstructured":"Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5\u20136\u00a0yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol. 1996;35:1106\u201315.","journal-title":"Br J Rheumatol"},{"key":"626_CR2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/art.1780340606","volume":"34","author":"JT Sharp","year":"1991","unstructured":"Sharp JT, Wolfe F, Mitchell DM, Bloch DA. The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum. 1991;34:660\u20138.","journal-title":"Arthritis Rheum."},{"key":"626_CR3","unstructured":"van der Heijde DM, van Leeuwen MA, van Riel PL, Koster AM, van 't Hof MA, van Rijswijk MH, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum. 1992;35:26\u201334","DOI":"10.1002\/art.1780350105","doi-asserted-by":"crossref"},{"key":"626_CR4","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L","volume":"44","author":"PM Welsing","year":"2001","unstructured":"Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 2001;44:2009\u201317.","journal-title":"Arthritis Rheum."},{"key":"626_CR5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.10513","volume":"47","author":"KW Drossaers-Bakker","year":"2002","unstructured":"Drossaers-Bakker KW, Zwinderman AH, Vliet Vlieland TP, Van Zeben D, Vos K, Breedveld FC, et al. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum. 2002;47:383\u201390.","journal-title":"Arthritis Rheum."},{"key":"626_CR6","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.22052","volume":"54","author":"D Aletaha","year":"2006","unstructured":"Aletaha D, Smolen J, Ward MM. Measuring function in rheumatoid arthritis: identifying reversible and irreversible components. Arthritis Rheum. 2006;54:2784\u201392.","journal-title":"Arthritis Rheum."},{"key":"626_CR7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/rheumatology\/40.3.297","volume":"40","author":"J Kirwan","year":"2001","unstructured":"Kirwan J, Byron M, Watt I. The relationship between soft tissue swelling, joint space narrowing and erosive damage in hand X-rays of patients with rheumatoid arthritis. Rheumatology (Oxford). 2001;40:297\u2013301.","journal-title":"Rheumatology (Oxford)."},{"key":"626_CR8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/ard.2010.146563","volume":"70","author":"R Landewe","year":"2011","unstructured":"Landewe R, van der Heijde D. Joint space narrowing, cartilage and physical function: are we deceived by measurements and distributions? Ann Rheum Dis. 2011;70:717\u20138.","journal-title":"Ann Rheum Dis."},{"key":"626_CR9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.2010.138693","volume":"70","author":"D Aletaha","year":"2011","unstructured":"Aletaha D, Funovits J, Smolen JS. Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction. Ann Rheum Dis. 2011;70:733\u20139.","journal-title":"Ann Rheum Dis."},{"key":"626_CR10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000;343:1594\u2013602.","journal-title":"N Engl J Med"},{"key":"626_CR11","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.20217","volume":"50","author":"EC Keystone","year":"2004","unstructured":"Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y, Teoh LS, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum. 2004;50:1400\u201311.","journal-title":"Arthritis Rheum."},{"key":"626_CR12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","volume":"363","author":"L Klareskog","year":"2004","unstructured":"Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet. 2004;363:675\u201381.","journal-title":"Lancet."},{"key":"626_CR13","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","volume":"50","author":"EW St Clair","year":"2004","unstructured":"St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum. 2004;50:3432\u201343.","journal-title":"Arthritis Rheum."},{"key":"626_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"FC Breedveld","year":"2006","unstructured":"Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006;54:26\u201337.","journal-title":"Arthritis Rheum."},{"key":"626_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","volume":"372","author":"P Emery","year":"2008","unstructured":"Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet. 2008;372:375\u201382.","journal-title":"Lancet."},{"key":"626_CR16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/art.20982","volume":"52","author":"JS Smolen","year":"2005","unstructured":"Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum. 2005;52:1020\u201330.","journal-title":"Arthritis Rheum."},{"key":"626_CR17","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/art.22143","volume":"54","author":"R Landewe","year":"2006","unstructured":"Landewe R, van der Heijde D, Klareskog L, van Vollenhoven R, Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum. 2006;54:3119\u201325.","journal-title":"Arthritis Rheum."},{"key":"626_CR18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.21678","volume":"54","author":"JS Smolen","year":"2006","unstructured":"Smolen JS, Van Der Heijde DM, St Clair EW, Emery P, Bathon JM, Keystone E, et al. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum. 2006;54:702\u201310.","journal-title":"Arthritis Rheum."},{"key":"626_CR19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3899\/jrheum.081018","volume":"36","author":"P Emery","year":"2009","unstructured":"Emery P, Genovese MC, van Vollenhoven R, Sharp JT, Patra K, Sasso EH. Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis. J Rheumatol. 2009;36:1429\u201341.","journal-title":"J Rheumatol."},{"key":"626_CR20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2008.090019","volume":"68","author":"JS Smolen","year":"2009","unstructured":"Smolen JS, Han C, van der Heijde DM, Emery P, Bathon JM, Keystone E, et al. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis. 2009;68:823\u20137.","journal-title":"Ann Rheum Dis."},{"key":"626_CR21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.37797","volume":"65","author":"NB Binder","year":"2013","unstructured":"Binder NB, Puchner A, Niederreiter B, Hayer S, Leiss H, Bluml S, et al. Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis. Arthritis Rheum. 2013;65:608\u201317.","journal-title":"Arthritis Rheum."},{"key":"626_CR22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/ard.2008.094128","volume":"68","author":"JS Smolen","year":"2009","unstructured":"Smolen JS, van der Heijde DM, Aletaha D, Xu S, Han J, Baker D, et al. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing. Ann Rheum Dis. 2009;68:1535\u201340.","journal-title":"Ann Rheum Dis."},{"key":"626_CR23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum."},{"key":"626_CR24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2009.118174","volume":"69","author":"R Landew\u00e9","year":"2010","unstructured":"Landew\u00e9 R, Ritchlin C, Olds M, Guerette B, Lavie F. Disconnect between disease activity and joint space narrowing for patients with psoriatic arthritis treated with adalimumab plus methotrexate but not for patients treated with methotrexate alone: case for cartilage protection through anti-TNF therapy. Ann Rheum Dis. 2010;69:700.","journal-title":"Ann Rheum Dis."},{"key":"626_CR25","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/ard.2008.097816","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landewe R, Fatenejad S, van der Heijde D. Subtle changes in individual joints result in both positive and negative change scores in a patient: results from a clinical trial in patients with rheumatoid arthritis. Ann Rheum Dis. 2009;68:1691\u20135.","journal-title":"Ann Rheum Dis."},{"key":"626_CR26","unstructured":"Goldring MB, Otero M, Tsuchimochi K, Ijiri K, Li Y. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis. 2008;67:iii75\u201382.","DOI":"10.1136\/ard.2008.098764","doi-asserted-by":"crossref"},{"key":"626_CR27","author":"DL Scott","year":"1993","unstructured":"Scott DL, van Riel PC, Van der Heidje DM, Studnicka-Benke A. Assessing disease activity in rheumatoid arthritis - The EULAR handbook of standard methods. On behalf of the EULAR Standing Committee for International Clinical Studies Including Therapeutic Trials - ESCISIT (Chairman: Smolen JS). EULAR: Zurich; 1993.","volume-title":"Assessing disease activity in rheumatoid arthritis - The EULAR handbook of standard methods. On behalf of the EULAR Standing Committee for International Clinical Studies Including Therapeutic Trials - ESCISIT (Chairman: Smolen JS)"},{"key":"626_CR28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ard.2003.007062","volume":"63","author":"RJ Wakefield","year":"2004","unstructured":"Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D, et al. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis. 2004;63:382\u20135.","journal-title":"Ann Rheum Dis."},{"key":"626_CR29","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/art.38016","volume":"65","author":"M Gartner","year":"2013","unstructured":"Gartner M, Mandl P, Radner H, Supp G, Machold KP, Aletaha D, et al. Sonographic joint assessment in rheumatoid arthritis: associations with clinical joint assessment during a state of remission. Arthritis Rheum. 2013;65:2005\u201314.","journal-title":"Arthritis Rheum."},{"key":"626_CR30","first-page":"518","volume":"24","author":"G Partsch","year":"1997","unstructured":"Partsch G, Steiner G, Leeb BF, Dunky A, Broll H, Smolen JS. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol. 1997;24:518\u201323.","journal-title":"J Rheumatol."},{"key":"626_CR31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2418","volume":"10","author":"JS Smolen","year":"2008","unstructured":"Smolen JS, Aletaha D, Grisar J, Redlich K, Steiner G, Wagner O. The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? Arthritis Res Ther. 2008;10:208.","journal-title":"Arthritis Res Ther."},{"key":"626_CR32","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/annrheumdis-2011-200386","volume":"71","author":"A Korb-Pap","year":"2012","unstructured":"Korb-Pap A, Stratis A, Muhlenberg K, Niederreiter B, Hayer S, Echtermeyer F, et al. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis. Ann Rheum Dis. 2012;71:1004\u201311.","journal-title":"Ann Rheum Dis."}],"container-title":"Arthritis Research & Therapy","original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0626-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T11:58:54Z","timestamp":1498219134000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,21]]},"references-count":32,"journal-issue":{"published-print":{"date-parts":[[2015,12]]},"issue":"1"},"alternative-id":["626"],"URL":"http:\/\/dx.doi.org\/10.1186\/s13075-015-0626-1","relation":{"cites":[]},"ISSN":["1478-6354"],"container-title-short":"Arthritis Res Ther","article-number":"133"}